A Phase I Study of LX22001 for Injection in Healthy Subjects
Clinical trial NCT06561542 · RECRUITING
Trial details
- NCT number
- NCT06561542
- Sponsor
- Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-05
- Primary completion
- 2025-11-21
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.